Adaptimmune Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADAP and other ETFs, options, and stocks.

About ADAP

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. 

CEO
Adrian Rawcliffe
CEOAdrian Rawcliffe
Employees
506
Employees506
Headquarters
Abingdon, Oxfordshire
HeadquartersAbingdon, Oxfordshire
Founded
2014
Founded2014
Employees
506
Employees506

ADAP Key Statistics

Market cap
49.14M
Market cap49.14M
Price-Earnings ratio
-0.28
Price-Earnings ratio-0.28
Dividend yield
—
Dividend yield—
Average volume
113.29M
Average volume113.29M
High today
$0.231
High today$0.231
Low today
$0.1555
Low today$0.1555
Open price
$0.205
Open price$0.205
Volume
69.06M
Volume69.06M
52 Week high
$0.9116
52 Week high$0.9116
52 Week low
$0.0403
52 Week low$0.0403

ADAP News

TipRanks 3d
Why Is Adaptimmune Therapeutics Stock Rising in Pre-Market Today?

Adaptimmune Therapeutics PLC (ADAP) is experiencing significant momentum in its stock performance. After a remarkable 52% surge on Wednesday, the penny stock is...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.